197 related articles for article (PubMed ID: 30341274)
1. Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.
He D; Yue Z; Li G; Chen L; Feng H; Sun J
Med Sci Monit; 2018 Oct; 24():7475-7481. PubMed ID: 30341274
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
3. Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection.
Gao W; Pang D; Yu S
J Int Med Res; 2019 May; 47(5):2116-2125. PubMed ID: 30922137
[TBL] [Abstract][Full Text] [Related]
4. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
5. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
6. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
Tan HY; Zheng YB; Liu J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
Wang DS; Zhong B; Zhang MS; Gao Y
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
[TBL] [Abstract][Full Text] [Related]
11. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer.
Wang YG; He Q; Guo SQ; Shi ZZ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8345-8353. PubMed ID: 31646564
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
[TBL] [Abstract][Full Text] [Related]
15. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-449a predicts survival outcome for colorectal cancer following curative resection: An observational study.
Fu D; Chen Y; Xu D
Medicine (Baltimore); 2021 Apr; 100(15):e25022. PubMed ID: 33847612
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
Yu H; Gao G; Jiang L; Guo L; Lin M; Jiao X; Jia W; Huang J
Int J Clin Exp Pathol; 2013; 6(12):2904-11. PubMed ID: 24294377
[TBL] [Abstract][Full Text] [Related]
20. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
